Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation
- PMID: 2232503
- DOI: 10.1038/ki.1990.252
Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation
Similar articles
-
Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.Urology. 1995 Jun;45(6):942-6. doi: 10.1016/s0090-4295(99)80112-5. Urology. 1995. PMID: 7771027
-
[New pathophysiologic aspects of nephrolithiasis].Schweiz Med Wochenschr. 1989 Jul 1;119(26):929-34. Schweiz Med Wochenschr. 1989. PMID: 2678432 Review. German.
-
Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.Trans Assoc Am Physicians. 1985;98:281-9. Trans Assoc Am Physicians. 1985. PMID: 3842199 No abstract available.
-
Protein inhibitors of crystallization.Semin Nephrol. 1991 Mar;11(2):98-109. Semin Nephrol. 1991. PMID: 2034929 Review. No abstract available.
-
Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.Braz J Med Biol Res. 2002 Oct;35(10):1165-72. doi: 10.1590/s0100-879x2002001000009. Epub 2002 Oct 13. Braz J Med Biol Res. 2002. PMID: 12424489
Cited by
-
Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.Urol Res. 1997;25(5):365-72. doi: 10.1007/BF01294667. Urol Res. 1997. PMID: 9373919
-
Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):426-30. doi: 10.1073/pnas.89.1.426. Proc Natl Acad Sci U S A. 1992. PMID: 1729712 Free PMC article.
-
Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.Urol Res. 1997;25(2):153-9. doi: 10.1007/BF01037933. Urol Res. 1997. PMID: 9144885
-
Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.Urolithiasis. 2017 Feb;45(1):43-56. doi: 10.1007/s00240-016-0953-y. Epub 2016 Nov 29. Urolithiasis. 2017. PMID: 27900407 Review.
-
Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation.Clin J Am Soc Nephrol. 2008 Sep;3(5):1494-503. doi: 10.2215/CJN.02040408. Epub 2008 Jul 2. Clin J Am Soc Nephrol. 2008. PMID: 18596115 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous